Profile data is unavailable for this security.
About the company
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
- Revenue in USD (TTM)44.50m
- Net income in USD-12.27m
- Incorporated2004
- Employees130.00
- LocationLENSAR Inc2800 Discovery Drive, Suite 100ORLANDO 32826United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://www.lensar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| electroCore, Inc. | 18.69m | -16.47m | 41.08m | 68.00 | -- | 9.14 | -- | 2.20 | -2.85 | -2.85 | 3.13 | 0.7486 | 1.16 | 1.30 | 54.34 | 274,897.10 | -102.35 | -70.73 | -177.94 | -88.96 | 82.70 | 75.81 | -88.12 | -352.82 | 1.18 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Cutera Inc | 196.64m | -157.56m | 41.35m | 430.00 | -- | -- | -- | 0.2103 | -7.89 | -7.89 | 9.86 | -9.60 | 0.4864 | 2.29 | 4.43 | 457,293.00 | -38.97 | -22.00 | -50.24 | -30.72 | 16.42 | 47.63 | -80.13 | -27.24 | 2.22 | -43.94 | 1.84 | -- | -15.86 | 5.47 | -97.76 | -- | 85.87 | -- |
| United Health Products Inc | 0.00 | -1.93m | 41.40m | 6.00 | -- | -- | -- | -- | -0.008 | -0.008 | 0.00 | -0.0073 | 0.00 | 0.00 | -- | 0.00 | -719.43 | -6,446.86 | -- | -- | -- | 53.19 | -- | -132,561.20 | 0.0483 | -15.60 | -- | -- | -100.00 | -- | -55.45 | -- | -- | -- |
| iCAD Inc | 17.94m | -5.14m | 41.93m | 67.00 | -- | 1.28 | -- | 2.34 | -0.1982 | -0.0894 | 0.6915 | 1.23 | 0.4081 | 0.9199 | 2.47 | 267,731.30 | -11.70 | -23.94 | -14.93 | -34.14 | 85.60 | 76.96 | -28.66 | -45.02 | 4.59 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
| IR-Med Inc | 0.00 | -4.22m | 41.99m | 6.00 | -- | -- | -- | -- | -0.0608 | -0.0608 | 0.00 | -0.0012 | 0.00 | -- | -- | 0.00 | -285.64 | -- | -463.30 | -- | -- | -- | -- | -- | -- | -- | 2.16 | -- | -- | -- | -3.70 | -- | -- | -- |
| Autonomix Medical Inc | 0.00 | -10.68m | 43.88m | 3.00 | -- | -- | -- | -- | -0.5055 | -0.5055 | 0.00 | -0.2649 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 84.50 | -- | -- | -- |
| Vaso Corp | 80.54m | 3.18m | 46.69m | 300.00 | 12.86 | 1.83 | 11.42 | 0.5797 | 0.0207 | 0.0207 | 0.4589 | 0.1459 | 1.16 | 20.03 | 7.77 | 268,470.00 | 4.57 | 7.60 | 7.44 | 16.62 | 61.83 | 58.39 | 3.95 | 5.82 | 1.37 | -- | 0.0091 | -- | 2.18 | 1.84 | -57.46 | -- | -22.33 | -- |
| Icecure Medical Ltd | 3.23m | -14.65m | 47.10m | 71.00 | -- | 3.87 | -- | 14.59 | -0.3211 | -0.3211 | 0.0708 | 0.266 | 0.1386 | 0.7518 | 35.68 | 45,478.88 | -62.89 | -54.89 | -76.33 | -68.66 | 40.26 | 49.87 | -453.76 | -313.19 | 3.08 | -- | 0.00 | -- | 4.67 | 23.50 | 13.70 | -- | 48.10 | -- |
| Lucid Diagnostics Inc | 2.98m | -54.53m | 47.73m | 70.00 | -- | -- | -- | 16.00 | -1.27 | -1.27 | 0.0698 | 0.2544 | 0.0735 | -- | 78.50 | 42,614.29 | -115.88 | -- | -248.82 | -- | -111.06 | -- | -1,576.63 | -- | 1.36 | -- | 0.5579 | -- | 544.03 | -- | 6.24 | -- | -- | -- |
| LENSAR Inc | 44.50m | -12.27m | 47.75m | 130.00 | -- | 1.50 | -- | 1.07 | -1.13 | -1.13 | 3.92 | 4.00 | 0.7536 | 1.32 | 9.79 | 342,307.70 | -20.78 | -30.97 | -25.12 | -36.94 | 50.45 | 51.04 | -27.57 | -52.30 | 2.36 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| Cytosorbents Corp | 36.69m | -27.54m | 48.88m | 186.00 | -- | 2.58 | -- | 1.33 | -0.5869 | -0.5869 | 0.7748 | 0.3486 | 0.7019 | 4.82 | 5.97 | 197,237.50 | -52.69 | -36.00 | -68.27 | -43.52 | 64.08 | 68.15 | -75.07 | -62.71 | 1.21 | -114.70 | 0.1896 | -- | 4.79 | 10.06 | 13.12 | -- | -9.24 | -- |
| Beyond Air Inc | 689.00k | -66.70m | 50.72m | 98.00 | -- | 1.88 | -- | 73.61 | -2.13 | -2.13 | 0.0219 | 0.5867 | 0.011 | 1.44 | 1.24 | 7,030.61 | -112.64 | -70.88 | -148.49 | -88.69 | -115.24 | -- | -10,288.68 | -1,530.31 | 3.26 | -- | 0.382 | -- | -- | -- | -29.27 | -- | -- | -- |
| DarioHealth Corp | 19.04m | -59.90m | 52.66m | 276.00 | -- | 0.664 | -- | 2.77 | -2.04 | -2.04 | 0.633 | 2.65 | 0.1555 | 2.34 | 3.57 | 69,000.00 | -43.90 | -73.26 | -51.33 | -87.59 | 27.56 | 29.54 | -282.38 | -293.54 | 2.67 | -- | 0.2673 | -- | -26.41 | 22.45 | 0.5091 | -- | 52.42 | -- |
| Envoy Medical Inc | 297.00k | -22.43m | 54.10m | 34.00 | -- | -- | -- | 182.14 | -2.21 | -2.21 | 0.0194 | -0.3782 | 0.0494 | 0.4737 | 2.36 | 8,735.29 | -381.38 | -- | -2,885.46 | -- | -118.18 | -- | -7,718.86 | -- | 0.8969 | -16.54 | -- | -- | 33.33 | -- | -87.83 | -- | -- | -- |
| Apyx Medical Corp | 50.45m | -22.81m | 55.43m | 252.00 | -- | 2.74 | -- | 1.10 | -0.6583 | -0.6583 | 1.46 | 0.5846 | 0.7914 | 1.77 | 4.49 | 200,202.40 | -35.94 | -25.24 | -46.73 | -29.97 | 63.70 | 66.11 | -45.41 | -46.00 | 4.94 | -9.21 | 0.6207 | -- | 17.61 | 25.82 | 19.28 | -- | 7.99 | -- |
Data as of May 24 2024. Currency figures normalised to LENSAR Inc's reporting currency: US Dollar USD
40.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| North Run Capital LPas of 07 May 2024 | 1.10m | 9.66% |
| Park West Asset Management LLCas of 31 Mar 2024 | 1.09m | 9.54% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 657.86k | 5.77% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 430.30k | 3.78% |
| Brandes Investment Partners LPas of 31 Mar 2024 | 330.95k | 2.90% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 328.35k | 2.88% |
| DCF Capital LLCas of 31 Mar 2024 | 238.23k | 2.09% |
| Clearline Capital LPas of 31 Mar 2024 | 173.00k | 1.52% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 146.63k | 1.29% |
| Geode Capital Management LLCas of 31 Mar 2024 | 90.71k | 0.80% |
More ▼
Data from 31 Mar 2024 - 07 May 2024Source: FactSet Research Systems Inc.
